MétaCan
Menu
Back to cohort
Record W4407736448 · doi:10.1097/qad.0000000000004161

Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus

2025· article· en· W4407736448 on OpenAlexaff
Mathieu Chalouni, Daniela K van Santen, Juan Berenguer, Inmaculada Jarrín, José M. Miró, Marina B. Klein, Jim Young, Jessie Torgersen, Christopher T. Rentsch, M. John Gill, Rachel Epstein, Benjamin P. Linas, Robert Zangerle, Bernard Surial, Andri Rauch, Giota Touloumi, Antonios Papadopoulos, Linda Wittkop, Marc van der Valk, Anders Boyd, Antonella d’Arminio Monforte, Massimo Puoti, Roger Logan, Sophia M. Rein, Miguel A. Hernán, Sara Lodi

Bibliographic record

VenueAIDS · 2025
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsMcGill UniversityAlberta Hip and Knee ClinicUniversity of CalgaryMcGill University Health Centre
FundersNational Institute on Drug AbuseGenentechCenter for AIDS Research, University of WashingtonViiV HealthcareGilead SciencesNational Institutes of HealthNational Institute of Allergy and Infectious DiseasesPfizer
KeywordsMedicineInterquartile rangeInternal medicineHepatitis CCoinfectionHepatocellular carcinomaHepatitis C virusTransmission (telecommunications)Human immunodeficiency virus (HIV)ImmunologyVirologyVirus

Abstract

fetched live from OpenAlex

OBJECTIVE: People with HIV-hepatitis C virus (HCV) co-infection need antiretroviral treatment (ART) to suppress HIV and direct-acting antivirals (DAAs) to cure HCV. ART is typically prioritized, but delays in DAA initiation may increase the risk of liver-related events and HCV transmission to others. DESIGN: Target trial emulation with observational data collected in routine clinical practice from a collaboration of cohorts from Europe and North America. METHODS: We included DAA-naive adults with HIV-HCV co-infection who achieved HIV virologic suppression (HIV RNA <50 copies/ml) after starting ART between 2013 and 2020. We estimated the probability of not initiating DAAs at 6 and 36 months after HIV virologic suppression and emulated a target trial of early (≤6 months after HIV virological suppression) versus delayed (>6 months) DAA initiation and the 36-month risk of liver-related events (liver decompensation or hepatocellular carcinoma). RESULTS: Of 862 eligible individuals (median age 46 years; interquartile range 36-56), 14% were women, and 52% had a history of injection drug use. The 6-month and 36-month probabilities of not initiating DAA were 58% [95% confidence interval (CI): 55-61] and 24% (21-27), respectively. The 36-month risk of liver-related events was 1.1% (0.4-2.0) for early initiation and 1.7% (0.7-2.5) for delayed initiation; risk difference -0.5% (-1.2 to 0.4). CONCLUSION: Almost one-quarter of people with HIV-HCV co-infection on ART had not initiated DAA 3 years after HIV virologic suppression. Because the 3-year risk of liver-related events was low, estimates of the impact of delayed DAA initiation were imprecise.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.040

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.019
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.283
Teacher spread0.272 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAIDSSame topicHepatitis C virus researchFrench-language works237,207